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Acute myocardial infarction (AMI) is a global 
leading cause of death in cardiovascular diseases. 
Stress is one of major factors predicting AMI [1]. 
The recurrence of AMI within a month after index 
hospitalization is very common in patients with 
cardiovascular diseases. Although the aspirin re-
sistence may be associated with the diagnosis of 
a definite AMI [2], the low and precisely regulated 
dose of aspirin might be helpful in AMI through 
the inhibition of dermicidin isoform-2 (DCN-2) 
(Fig. 1 — f) i.e. expulsion of platelet bound DCN-2 
from AMI plasma [3].
The atherosclerotic plaques are responsible 
for the initiation of cell death by inhibiting the 
supply of O2, glucose, nutrients, and minerals to 
the site of injury [4]. In consequence, cells in the 
affected site start to die, being unable to continue 
core metabolic processes.
Free radical-induced oxidative stress is fre-
quent in AMI patients. Catalase is a free-radical 
reductor that helps in the inhibition of platelet 
aggregation [5]. Different types of free radicals 
and H2O2 are generated at the time of platelet ag-
gregation. Catalase acts as a crucial defender by de-
stroying stress-induced free radicals, such as H2O2, 
helps in platelet aggregation inhibition, and subse-
quently saves the cells from death (Fig. 1 — g, g’). 
The prevention of cell death is also caused by the cas-
pase inhibition via catalase activation (Fig. 1 — h) [6]. 
It has also been reported that DCN-2, an envi-
ronmentally stress-induced 11 kDa protein, is 
involved in the prognosis of AMI. The concentra-
tion of DCN-2 protein is significantly higher in 
AMI circulation as compared to acute coronary 
syndrome patients and normal plasma [3]; it is 
a potent inhibitor of all forms of nitric oxide syn-
thases (NOS) and an activator of platelet aggrega-
tion [3]. As a result, thrombus formation starts 
to progress, leading to cell death (Fig. 1 — i). 
Low-dose-aspirin and insulin are decisively consid-
ered to be inhibitors of DCN-2 [3]. Actually, DCN-2 
was able to nullify the effect of aspirin and insulin. 
Thus, aspirin was unable to inhibit the platelet ag-
gregation in AMI patients. This action is related 
to the respective synthesis rate/kinetics and local 
persistence of the endogenous substances in vivo, 
i.e. dermcidin-2 and insulin. In a severe stressful 
condition, a dominating concentration of DCN-2 
may nullify aspirin and insulin effects. However, 
if we focus on the stepwise effects of DCN-2, i.e. 
binding on the platelet surface followed by the 
aggregation of platelets due to the inhibition of 
nitric oxide (NO) production, and accordingly an-
tagonizing the effects stepwise manner, we could 
get substantially  greater success. Hereby we show 
unique dosing of aspirin and insulin in a biphasic 
manner. The first dose of aspirin would be capable 
of removing the platelet-bound dermcidin from its 
high affinity binding sites through the production of 
NO, but it was incapable of inhibiting the platelet 
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aggregation. Insulin or NO could be used instead 
of aspirin at first dose. After removal of dermcidin 
from the platelet surface, platelets become su-
persensitive to the aspirin and the second dose of 
aspirin is able to inhibit the platelet aggregation 
in AMI. Both of these organic (aspirin) and physi-
ological (insulin) compounds were able to produce 
NO through the activation of aspirin-activated 
NOS [7] and insulin-activated NOS [8], respec-
tively, and eliminated the effect of dermcidin [3]. 
It has also been reported before that insulin is an 
antithrombotic factor [9]. The high level of DCN-2 
(0.4 µM) in AMI subjects is the cause of massive 
platelet aggregation. Due to the fact that DCN-2 is 
a stress-induced component, as H2O2 and other free 
radicals, it can directly activate platelet aggregation 
in AMI (Fig. 1 — a, b, c, d, e). Moreover, it becomes 
responsible for the cell death in the case of AMI 
(Fig. 1 — a, b, c, d) and also causes the failure of 
the aspirin-effect. Specific amounts of insulin and 
aspirin were able to neutralize the effect of DCN-2 
through the production of NO and as such, 
cell death might be inhibited by this signaling 
molecule through the inhibition of Fas expression 
(Fig. 1 — k, l, m). We have already reported that 
exact amount of aspirin or insulin was able to pro-
duce NO. Precisely regulated psychological level 
of NO is a very important messenger molecule that 
plays an instrumental role in different cells and 
tissues of various functions. One of the essential 
roles of NO is to inhibit the unnatural cell death 
in AMI  by impairing the Fas expression (Fig. 1 
— k, l, m) [10]. Fas (Apo-1 or CD95) represents 
a well-known death receptor that is activated by 
its cognate — Fas ligand. Fas binding stimulates 
receptor trimerization and sequential recruitment 
of the adapter molecule Fas-associated death do-
main. The NO action impairs this signaling cascade.
On the other hand, if the availability of catalase 
in an AMI patient remains normal, cell death in 
AMI might be inhibited due to the reduction of free 
radicals during platelet aggregation. Therefore, by 
the interactive role of theTRIAD system (catalase, 
insulin, and aspirin), the cell death in AMI can be 
stopped and even the consequence of the recur-
rence of AMI due to the negative effect of DCN-2 
could be prevented (Fig. 1). As a result, it can also 
be argued that if we were able to inhibit NOS in the 
heart by gene silencing through double stranded 
RNA-interference pathway, it would be better to 
Figure 1. The figure demonstrates dermcidin isoform-2 and a stress protein-mediated platelet aggregation, followed 
by cell death in acute myocardial infarction (AMI) subjects. It subsequently indicates that the TRIAD system insulin, 
low dose aspirin and catalase would be capable of neutralizing the dermcidin effect mainly through nitric oxide (NO) 
pathway.
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understand the efficacy of the TRIAD system on 
DCN-2.
In this context, our report explains the mecha-
nism of cell death occurrence in AMI patients by 
the stress-induced protein DCN-2. This paper 
provides explanation how cell death can be pre-
vented, and recurrence of the disease stopped, by 
a unique solution of maintaining catalase, insulin, 
and low-dose-aspirin in AMI patients.
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